Please use a PC Browser to access Register-Tadawul
Get It
Leerink Partners Initiates Coverage On MapLight Therapeutics with Outperform Rating, Announces Price Target of $30
MapLight Therapeutics, Inc. MPLT | 19.79 19.79 | +6.92% 0.00% Pre |
